RPRX logo

Royalty Pharma (RPRX) Retained earnings

annual retained earnings:

$2.85B+$328.07M(+13.03%)
December 31, 2024

Summary

  • As of today (May 21, 2025), RPRX annual retained earnings is $2.85 billion, with the most recent change of +$328.07 million (+13.03%) on December 31, 2024.
  • During the last 3 years, RPRX annual retained earnings has risen by +$590.47 million (+26.18%).
  • RPRX annual retained earnings is now at all-time high.

Performance

RPRX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

quarterly retained earnings:

$2.48B-$364.99M(-12.83%)
March 31, 2025

Summary

  • As of today (May 21, 2025), RPRX quarterly retained earnings is $2.48 billion, with the most recent change of -$364.99 million (-12.83%) on March 31, 2025.
  • Over the past year, RPRX quarterly retained earnings has increased by +$53.22 million (+2.19%).
  • RPRX quarterly retained earnings is now -12.83% below its all-time high of $2.85 billion, reached on December 31, 2024.

Performance

RPRX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

RPRX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.0%+2.2%
3 y3 years+26.2%+11.5%
5 y5 years+0.7%-3.2%

RPRX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+44.8%-12.8%+26.3%
5 y5-yearat high+48.2%-12.8%+57.9%
alltimeall timeat high+134.0%-12.8%+57.9%

RPRX Retained earnings History

DateAnnualQuarterly
Mar 2025
-
$2.48B(-12.8%)
Dec 2024
$2.85B(+13.0%)
$2.85B(+2.9%)
Sep 2024
-
$2.76B(+16.2%)
Jun 2024
-
$2.38B(-2.0%)
Mar 2024
-
$2.43B(-3.6%)
Dec 2023
$2.52B(+28.1%)
$2.52B(+17.9%)
Sep 2023
-
$2.13B(-5.2%)
Jun 2023
-
$2.25B(+1.6%)
Mar 2023
-
$2.22B(+12.8%)
Dec 2022
$1.96B
$1.96B(-21.6%)
Sep 2022
-
$2.50B(+2.4%)
DateAnnualQuarterly
Jun 2022
-
$2.45B(+10.0%)
Mar 2022
-
$2.22B(-1.4%)
Dec 2021
$2.26B(+17.4%)
$2.26B(-2.8%)
Sep 2021
-
$2.32B(+1.3%)
Jun 2021
-
$2.29B(+19.1%)
Mar 2021
-
$1.92B(+0.2%)
Dec 2020
$1.92B(-32.0%)
$1.92B(+6.3%)
Sep 2020
-
$1.81B(+15.0%)
Jun 2020
-
$1.57B(-38.7%)
Mar 2020
-
$2.56B(-9.3%)
Dec 2019
$2.83B(+132.3%)
$2.83B
Dec 2018
$1.22B
-

FAQ

  • What is Royalty Pharma annual retained earnings?
  • What is the all time high annual retained earnings for Royalty Pharma?
  • What is Royalty Pharma annual retained earnings year-on-year change?
  • What is Royalty Pharma quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Royalty Pharma?
  • What is Royalty Pharma quarterly retained earnings year-on-year change?

What is Royalty Pharma annual retained earnings?

The current annual retained earnings of RPRX is $2.85B

What is the all time high annual retained earnings for Royalty Pharma?

Royalty Pharma all-time high annual retained earnings is $2.85B

What is Royalty Pharma annual retained earnings year-on-year change?

Over the past year, RPRX annual retained earnings has changed by +$328.07M (+13.03%)

What is Royalty Pharma quarterly retained earnings?

The current quarterly retained earnings of RPRX is $2.48B

What is the all time high quarterly retained earnings for Royalty Pharma?

Royalty Pharma all-time high quarterly retained earnings is $2.85B

What is Royalty Pharma quarterly retained earnings year-on-year change?

Over the past year, RPRX quarterly retained earnings has changed by +$53.22M (+2.19%)
On this page